Search Results - "SCHUHMACHER, Jochen"

Refine Results
  1. 1

    DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours by Zhang, Hanwen, Schuhmacher, Jochen, Waser, Beatrice, Wild, Damian, Eisenhut, Michael, Reubi, Jean Claude, Maecke, Helmut R

    “…We aimed at designing and developing a novel bombesin analogue, DOTA-PEG(4)-BN(7-14) (DOTA-PESIN), with the goal of labelling it with (67/68)Ga and (177)Lu for…”
    Get full text
    Journal Article
  2. 2

    Conjugation of DOTA Using Isolated Phenolic Active Esters:  The Labeling and Biodistribution of Albumin as Blood Pool Marker by Mier, Walter, Hoffend, Johannes, Krämer, Susanne, Schuhmacher, Jochen, Hull, William E, Eisenhut, Michael, Haberkorn, Uwe

    Published in Bioconjugate chemistry (01-01-2005)
    “…A convenient method for the functionalization of proteins with DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) has been developed. For this…”
    Get full text
    Journal Article
  3. 3

    A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases by Froidevaux, Sylvie, Calame-Christe, Martine, Schuhmacher, Jochen, Tanner, Heidi, Saffrich, Rainer, Henze, Markus, Eberle, Alex N

    Published in The Journal of nuclear medicine (1978) (01-01-2004)
    “…Although (18)F-FDG PET is widely used for metastatic melanoma diagnosis, it is less accurate than desirable, particularly for small foci. Since both melanotic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics by Kipriyanov, Sergey M, Moldenhauer, Gerhard, Schuhmacher, Jochen, Cochlovius, Björn, Von der Lieth, Claus-Wilhelm, Matys, E.Ronald, Little, Melvyn

    Published in Journal of molecular biology (15-10-1999)
    “…To increase the valency, stability and therapeutic potential of bispecific antibodies, we designed a novel recombinant molecule that is bispecific and…”
    Get full text
    Journal Article
  6. 6

    Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo by Hoffend, Johannes, Mier, Walter, Schuhmacher, Jochen, Schmidt, Kerstin, Dimitrakopoulou-Strauss, Antonia, Strauss, Ludwig G., Eisenhut, Michael, Kinscherf, Ralf, Haberkorn, Uwe

    Published in Nuclear medicine and biology (01-04-2005)
    “…Investigations into tumor angiogenesis and antiangiogenic treatment have renewed interest in tumor perfusion. To image tumor blood-pool by PET, suitable…”
    Get full text
    Journal Article
  7. 7

    Characterization of ^sup 68^Ga-DOTA-D-Phe^sup 1^-Tyr^sup 3^-Octreotide Kinetics in Patients with Meningiomas by Henze, Marcus, Dimitrakopoulou-Strauss, Antonia, Milker-Zabel, Stefanie, Schuhmacher, Jochen

    Published in The Journal of nuclear medicine (1978) (01-05-2005)
    “…Because biopsy has a high risk of hemorrhage and the findings of CT and MRI are often ambiguous, especially at the base of the skull, additional methods for…”
    Get full text
    Journal Article
  8. 8

    GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a ^sup 68^Ga-Labeled Bombesin(6-14) Analog by Schuhmacher, Jochen, Zhang, Hanwen, Doll, Josef, Mäcke, Helmut R

    Published in The Journal of nuclear medicine (1978) (01-04-2005)
    “…Bombesin (BN), a 14-amino-acid peptide, shows high affinity for the human gastrin-releasing peptide receptor (GRP-r), which is overexpressed on several types…”
    Get full text
    Journal Article
  9. 9

    Conjugation of DOTA using isolated phenolic active esters: The labelingand biodistribution of albumin as blood pool marker by Mier, Walter, Hoffend, Johannes, Kramer, Susanne, Schuhmacher, Jochen

    Published in Bioconjugate chemistry (01-01-2005)
    “…A convenient method for the functionalization of proteins with DOTA (1,4,7,10-tetraazacyclododecane1,4,7,10-tetraacetic acid) has been developed. For this…”
    Get full text
    Journal Article
  10. 10

    Immunoscintigraphy with positron emission tomography : Gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies by SCHUHMACHER, Jochen, KAUL, Sepp, KLIVENYI, Gabor, JUNKERMANN, Hans, MAGENER, Achim, HENZE, Marcus, DOLL, Josef, HABERKORN, Uwe, AMELUNG, Folker, BASTERT, Gunther

    Published in Cancer research (Baltimore) (01-05-2001)
    “…Pretargeting techniques that are based on the sequential administrations of bispecific antitumor/antimetal chelate antibodies (BS-MAbs), a blocker to saturate…”
    Get full text
    Conference Proceeding Journal Article
  11. 11

    Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells by Cochlovius, B, Kipriyanov, S M, Stassar, M J, Christ, O, Schuhmacher, J, Strauss, G, Moldenhauer, G, Little, M

    Published in The Journal of immunology (1950) (15-07-2000)
    “…The use of anti-CD3 x antitumor bispecific Abs is an attractive and highly specific approach in cancer therapy. Recombinant Ab technology now provides powerful…”
    Get full text
    Journal Article
  12. 12

    Contribution of paramagnetic trace elements to the spin-lattice relaxation time in the liver by Schuhmacher, J H, Matys, E R, Clorius, J H, Hauser, H, Wesch, H, Maier-Borst, W

    Published in Investigative radiology (01-09-1985)
    “…The relaxation times of water protons in rat liver tissue were measured with a NMR spectrometer at 20 MHz. The paramagnetic trace elements Cu, Fe, and Mn were…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Stable Expression of Soluble Therapeutic Peptides in Eukaryotic Cells by Multimerisation: Application to the HIV-1 Fusion Inhibitory Peptide C46 by Dervillez, Xavier, Hüther, Alexandra, Schuhmacher, Jochen, Griesinger, Christian, Cohen, Jacques H., von Laer, Dorothee, Dietrich, Ursula

    Published in ChemMedChem (13-03-2006)
    “…A major drawback of therapeutic peptides is their short half‐life, which results in the need for multiple applications and high synthesis costs. To overcome…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A Gallium-Labeled DOTA-{alpha}-Melanocyte- Stimulating Hormone Analog for PET Imaging of Melanoma Metastases by Froidevaux, Sylvie, Calame-Christe, Martine, Schuhmacher, Jochen, Tanner, Heidi, Saffrich, Rainer, Henze, Markus, Eberle, Alex N

    Published in The Journal of nuclear medicine (1978) (01-01-2004)
    “…Although (18)F-FDG PET is widely used for metastatic melanoma diagnosis, it is less accurate than desirable, particularly for small foci. Since both melanotic…”
    Get full text
    Journal Article
  17. 17

    GRP Receptor-Targeted PET of a Rat Pancreas Carcinoma Xenograft in Nude Mice with a 68Ga-Labeled Bombesin(6-14) Analog by Schuhmacher, Jochen, Zhang, Hanwen, Doll, Josef, Macke, Helmut R, Matys, Ronald, Hauser, Harald, Henze, Marcus, Haberkorn, Uwe, Eisenhut, Michael

    Published in The Journal of nuclear medicine (1978) (01-04-2005)
    “…Bombesin (BN), a 14-amino-acid peptide, shows high affinity for the human gastrin-releasing peptide receptor (GRP-r), which is overexpressed on several types…”
    Get full text
    Journal Article
  18. 18

    Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide Kinetics in Patients with Meningiomas by Henze, Marcus, Dimitrakopoulou-Strauss, Antonia, Milker-Zabel, Stefanie, Schuhmacher, Jochen, Strauss, Ludwig G, Doll, Josef, Macke, Helmut R, Eisenhut, Michael, Debus, Jurgen, Haberkorn, Uwe

    Published in The Journal of nuclear medicine (1978) (01-05-2005)
    “…Because biopsy has a high risk of hemorrhage and the findings of CT and MRI are often ambiguous, especially at the base of the skull, additional methods for…”
    Get full text
    Journal Article
  19. 19

    Pretargeting of human mammary carcinoma xenografts with bispecific anti-MUC1/anti-Ga chelate antibodies and immunoscintigraphy with PET by SCHUHMACHER, Jochen, KLIVENYI, Gabor, KAUL, Sepp, HENZE, Marcus, MATYS, Ronald, HAUSER, Harald, CLORIUS, John

    Published in Nuclear medicine and biology (01-10-2001)
    “…We recently demonstrated the feasibility of combining enhanced tumor-to-tissue contrast and PET imaging for immunoscintigraphic tumor localization in pancreas…”
    Get full text
    Journal Article
  20. 20